This page includes the latest FDA filings for La Jolla Pharmaceutical Co. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | LJPC | DUNS 613541192 |
Device Company | Device | Date |
|---|---|---|
| La Jolla Pharmaceutical Company, Bora Pharmaceuticals Injectables Inc. | Prescription Medication | 2024-11-27 |
| La Jolla Pharmaceutical Company, Bora Pharmaceuticals Injectables Inc. | Prescription Medication | 2023-01-12 |
| La Jolla Pharmaceutical Company | Giapreza | 2022-09-15 |
| La Jolla Pharmaceutical Company, Bora Pharmaceuticals Injectables Inc. | Prescription Medication | 2022-09-15 |
| La Jolla Pharmaceutical Company, Bora Pharmaceuticals Injectables Inc. | Prescription Medication | 2020-06-22 |
| La Jolla Pharmaceutical Company, Bora Pharmaceuticals Injectables Inc. | Prescription Medication | 2020-06-17 |
| La Jolla Pharmaceutical Company, Bora Pharmaceuticals Injectables Inc. | Prescription Medication | 2019-12-31 |
| La Jolla Pharmaceutical Company, Bora Pharmaceuticals Injectables Inc. | Prescription Medication | 2018-08-01 |
| La Jolla Pharmaceutical Company | Giapreza | 2018-02-05 |
| NCAGE Code | 83BJ3 | LA JOLLA PHARMACEUTICAL COMPANY |
| CAGE Code | 83BJ3 | LA JOLLA PHARMACEUTICAL COMPANY |
| S.A.M. Registration | 83BJ3 [613541192] | LA JOLLA PHARMACEUTICAL COMPANY |
| SEC | 0000920465 | LA JOLLA PHARMACEUTICAL CO of CALIFORNIA |